Effects of drug unification on immunohistochemical. A. Heart tissues. B. Liver tissues. C. Kidney tissues. (1) Control group; (2) diabetes model group; (3) model group of combined disease; (4) rosiglitazone group; (5) rofecoxib group; (6) celecoxib group; (7) treatmented with rosiglitazone and rofecoxib group; (8) treatmented with rosiglitazone and celecoxib group. (Scale bars = 100 um).